IHS Chemical Week

People & Business :: Companies

Pfizer Gets Approval from European Commission for $68-Billion Wyeth Acquisition

1:56 AM MDT | July 20, 2009 | Deepti Ramesh

Pfizer says that the European Commission, under the European Union Merger Regulation, has approved Pfizer’s previously announced acquisition of Wyeth for a total of $68 billion. Pfizer agreed to acquire Wyeth in January 2009 in a deal that the companies say will create one of the most diversified health care firms worldwide. The merged company would offer a broad product portfolio including 17 products with more than $1 billion/year each in revenue. No drug is expected to account for more than 10% of the combined entity’s revenue in...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa